 Waipo's SCP is the forum for the international development of patent law. The committee wrapped up its final meeting on December 15th of this year. Marco Alamon is the committee secretary. Marco, give us a quick rundown on what happened during the week. It was a very intensive week of work. We have the chance of an important number of patent experts and delegates coming from capital that brought not only a great level of knowledge and expertise, but also important and very valid technical questions. Through this debate and exchange is how we foresee chances for the international patent system to progress. At the same time, all the important issues, mainly policy issues, complex policy issues, like in the areas of patent and health, were part of the discussions. Those proved to be very difficult ones and those throughout the discussions shows how difficult it is to get an agreement on those complete issues when it comes to the discussions for future work. So you said that public health was a difficult issue. Where was progress both achieved? We reached important programs in areas like, for example, discussions on the issue of quality. An entire session on one of the elements of the consideration of what quality means for the patent system, that is the discussion on inventive steps, proved to be an extremely positive one. Not only those delegates that made presentations on quality, but participants engaged in the discussions learned a lot. So what's on the agenda for the next session? For the next session, we will continue discussions on the five agenda items, the eating of quality, the eating of exceptional limitations, the eating of patents and health, the eating of transfer of technology, and the eating of client attorney privilege. So discussions will continue. There will be two concrete areas of work. One is a repo of the secretariat on questionnaire on quality that I'm sure will help the committee to improve discussion in this important area. And second one is a study on patent-related flexibilities in the health area, particularly how those flexibilities will facilitate access to medicines and more in concrete essential medicines in developing and least developed countries.